Compare PALI & CD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PALI | CD |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | 11 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.2M | 284.2M |
| IPO Year | 2019 | N/A |
| Metric | PALI | CD |
|---|---|---|
| Price | $1.98 | $4.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 143.5K |
| Earning Date | 05-11-2026 | 08-31-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | $949,544.10 |
| Revenue Next Year | N/A | $14.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $3.09 |
| 52 Week High | $2.64 | $14.10 |
| Indicator | PALI | CD |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 43.78 |
| Support Level | $1.58 | $3.64 |
| Resistance Level | $2.12 | $6.39 |
| Average True Range (ATR) | 0.14 | 0.56 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 55.13 | 48.43 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.